{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T10:55:00Z","timestamp":1791888900817,"version":"4.3.4"},"reference-count":19,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.3892\/mco.2016.1100","type":"journal-article","created":{"date-parts":[[2016,12,5]],"date-time":"2016-12-05T10:21:53Z","timestamp":1480933313000},"page":"255-257","source":"Crossref","is-referenced-by-count":30,"title":["Osteonecrosis of the jaw associated with everolimus: A case report"],"prefix":"10.3892","volume":"6","author":[{"given":"Daigo","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Tsubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Utsunomiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Sueoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiko","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayoko","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiro","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Kon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2016,12,5]]},"reference":[{"key":"key20180107152220_b1-mco-0-0-1100","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1007\/s00259-004-1538-5","article-title":"The curability of breast cancer and the treatment of advanced disease","volume":"31","author":"Guarneri","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"key20180107152220_b2-mco-0-0-1100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-0-387-74039-3_1","article-title":"Overview of resistance to systemic therapy in patients with breast cancer","volume":"608","author":"Gonzalez-Angulo","year":"2007","journal-title":"Adv Exp Med Biol"},{"key":"key20180107152220_b3-mco-0-0-1100","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00000658-200209000-00006","article-title":"2nd: Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: Effective clinical downstaging allows breast preservation and predicts outstanding local control and survival","volume":"236","author":"Cance","year":"2002","journal-title":"Ann Surg"},{"key":"key20180107152220_b4-mco-0-0-1100","volume-title":"Cancer Facts & Figures 2014","author":"American Cancer Society","year":"2014"},{"key":"key20180107152220_b5-mco-0-0-1100","doi-asserted-by":"crossref","first-page":"djv212","DOI":"10.1093\/jnci\/djv212","article-title":"Enhancing endocrine therapy for hormone receptor-positive advanced breast cancer: Cotargeting signaling pathways","volume":"107","author":"Johnston","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"key20180107152220_b6-mco-0-0-1100","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10549-010-0866-3","article-title":"Bevacizumab and osteonecrosis of the jaw: Incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer","volume":"122","author":"Guarneri","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"key20180107152220_b7-mco-0-0-1100","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.oooo.2012.05.017","article-title":"Intravenous bisphosphonate-related osteonecrosis of the jaw: Long-term follow-up of 109 patients","volume":"115","author":"Watters","year":"2013","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"key20180107152220_b8-mco-0-0-1100","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1016\/j.oooo.2013.02.001","article-title":"Osteonecrosis of the mandible associated with bevacizumab therapy","volume":"115","author":"Santos-Silva","year":"2013","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"key20180107152220_b9-mco-0-0-1100","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000201931","article-title":"Combination of bisphosphonates and antiangiogenic factors induces osteonecrosis of the jaw more frequently than bisphosphonates alone","volume":"76","author":"Christodoulou","year":"2009","journal-title":"Oncology"},{"key":"key20180107152220_b10-mco-0-0-1100","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.tripleo.2011.06.023","article-title":"Sunitinib related osteonecrosis of jaw: A case report","volume":"113","author":"Fleissig","year":"2012","journal-title":"Oral SurgOral Med Oral Pathol Oral Radiol"},{"key":"key20180107152220_b11-mco-0-0-1100","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"key20180107152220_b12-mco-0-0-1100","first-page":"139","article-title":"Osteonecrosis of the jaw in a patient with rheumatoid arthritis treated with an oral aminobisphosphonate: A clinical case report","volume":"10","author":"Longato","year":"2013","journal-title":"Clin Cases Miner Bone Metab"},{"key":"key20180107152220_b13-mco-0-0-1100","first-page":"20","article-title":"Osteonecrosis of the jaw related to everolimus and bisphosphonate: A unique case report?","volume":"4","author":"Giancola","year":"2013","journal-title":"Ann Stomatol (Roma)"},{"key":"key20180107152220_b14-mco-0-0-1100","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.1016\/j.bjoms.2013.09.008","article-title":"Osteonecrosis of the jaw related to everolimus: A case report","volume":"51","author":"Kim","year":"2013","journal-title":"Br J Oral Maxillofac Surg"},{"key":"key20180107152220_b15-mco-0-0-1100","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.bone.2004.07.013","article-title":"Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts","volume":"35","author":"Kneissel","year":"2004","journal-title":"Bone"},{"key":"key20180107152220_b16-mco-0-0-1100","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000313787","article-title":"Bisphosphonates induce apoptosis of circulating endothelial cells in multiple myeloma patients and in subjects with bisphosphonate-induced osteonecrosis of the jaws","volume":"124","author":"Allegra","year":"2010","journal-title":"Acta Haematol"},{"key":"key20180107152220_b17-mco-0-0-1100","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1158\/1078-0432.CCR-08-2057","article-title":"mTOR inhibitor RAD001 (everolimus) has antiangiogenic\/vascular properties distinct from a VEGFR tyrosine kinase inhibitor","volume":"15","author":"Lane","year":"2009","journal-title":"Clin Cancer Res"},{"key":"key20180107152220_b18-mco-0-0-1100","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/SPC.0b013e32833d303b","article-title":"Updates on osteonecrosis of the jaw","volume":"4","author":"Yamashita","year":"2010","journal-title":"Curr Opin Support Palliat Care"},{"key":"key20180107152220_b19-mco-0-0-1100","first-page":"c85","article-title":"Physiology and pharmacology of nonbisphosphonate drugs implicated in osteonecrosis of the jaw","volume":"78","author":"Troeltzsch","year":"2012","journal-title":"J Can Dent Assoc"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mco.2016.1100\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T15:22:30Z","timestamp":1515338550000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mco.2016.1100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,5]]},"references-count":19,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,12,5]]},"published-print":{"date-parts":[[2017,2]]}},"alternative-id":["10.3892\/mco.2016.1100"],"URL":"https:\/\/doi.org\/10.3892\/mco.2016.1100","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,5]]}}}